Editorial – Medical marijuana

Editorial originally appeared in The Topeka Capital-Journal

It is extremely concerning to me that our local media is just blindly accepting the medical marijuana legislation instead of questioning very serious elements.

Why are we allowing the legislature to bypass the FDA for approving “medication?” All other medication’s have been required to go through the FDA approval processes

Why are we allowing the use of marijuana for illnesses or conditions that have zero or little research science behind them?

Why are we willing to accept an extremely high dose level of THC that has been clearly demonstrated to cause episodes of psychosis?

How are we going to deal with patients that want to smoke pot while they are hospitalized for other conditions. Will hospitals be required to carry marijuana?

Will malpractice lawsuits increase because of serious side effects from Marijuana recommendations?

Why are we not hearing about all of the negative experiences from other states that have succumbed to medical marijuana. There is tremendous evidence that allowing medical marijuana was a mistake

News media needs to be asking these questions and pushing back on a dangerous and potentially harmful legislative action.

If you don’t trust my opinion, I would be happy to connect you with a host of physicians from other states that have been dealing with this.

Eric Voth MD.

Like this article?

Share on Facebook
Share on Twitter
Share on Linkdin
Share on Pinterest

Related Posts

IASIC Speaker Series Presents  Cannabis and Mental Health

The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,

Placebo Effect a Major Driver of Pain Reduction in Cannabis Trials

A strong placebo response may be largely responsible for the significant pain reduction observed in clinical trials of cannabis-based therapies, results of a new meta-analysis suggest. Investigators found that while the effect size of cannabinoids on pain intensity was significant, the placebo effect was about the same. “The data from the present meta-analysis, including 1459

Trends in Cannabis Use Disorder Diagnoses in the U.S. Veterans Health Administration, 2005–2019

Since 2005, diagnoses of cannabis use disorder have increased substantially among VHA patients, as they have in the general population and other patient populations. Possible explanations warranting investigation include decreasing perception of risk, changing laws, increasing cannabis potency, stressors related to growing socioeconomic inequality, and use of cannabis to self-treat pain. Clinicians and the public

Cannabis legalization and cannabis-involved pregnancy hospitalizations in Colorado

The primary objective of this study was to evaluate the association between presence of recreational cannabis dispensaries and prevalence of cannabis-involved pregnancy hospitalizations in Colorado. This was a retrospective cohort study of pregnancy-related hospitalizations co-coded with cannabis diagnosis codes in the Colorado Hospital Association from January 1, 2011, through December 31, 2018 (recreational cannabis began

Scroll to Top